Brimonidine tartrate is a salt form of brimonidine, a quinoxaline derivative and alpha-2 adrenergic receptor agonist used as an active pharmaceutical ingredient. It is primarily supplied as a raw material for the manufacturing of ophthalmic formulations.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 70359-46-5
Brimonidine tartrate
pharmaceutical raw material
Brimonidine
pharmaceutical raw material
Lornoxicam
pharmaceutical raw material
Pefloxacin mesylate
pharmaceutical raw material
Norfloxacin
pharmaceutical raw material
Mitoxantrone hydrochloride
pharmaceutical raw material
N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
pharmaceutical raw material
5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine;(2R,3R)-2,3-dihydroxybutanedioic acid
QZHBYNSSDLTCRG-LREBCSMRSA-N
C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O